Plus Therapeutics Inc <PSTV.OQ> expected to post a loss of 9 cents a share - Earnings Preview

• Plus Therapeutics Inc PSTV.OQ PSTV.O is expected to show a rise in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025

• The Austin Texas-based company is expected to report a 16.2% increase in revenue to $1.486 million from $1.28 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Plus Therapeutics Inc is for a loss of 9 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Plus Therapeutics Inc is $4.00, about 81% above its last closing price of $0.76

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated August 8 at 12:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)